Obesity
Coverage of Obesity in the Nexus archive.
- LSU and FMOL Health award research grants targeting state’s critical health needs
LSU and FMOL Health | Our Lady of the Lake have awarded over $1.6 million in research grants to seven teams through the Collaboration in Action Program (CAP), targeting critical health challenges in Louisiana. The funded projects focus on areas such as cancer, trauma care, chronic disease, obesity, sports medicine, brain health, and medical data science, utilizing technologies like wearable devices and machine learning to improve patient outcomes.
- Three deaths tied to Chicago-area heat wave
Three deaths in Chicago were linked to a recent heat wave, with autopsies showing heat stress as a complicating factor in each case. Health officials warned that extreme heat poses risks for individuals with chronic conditions and limited access to air conditioning. The heat wave began on June 29, referencing Chicago's 1995 heat wave that caused 739 deaths.
- Major review finds link between early screen exposure and developmental concerns
A major UK review found that screen exposure before age two is linked to developmental concerns, including sleep problems, delayed language, and behavioral challenges. Over 70% of babies and toddlers use digital devices, with some spending hours daily on screens. The American Academy of Pediatrics recommends avoiding most screen time for children under 18-24 months.
- Over-40s with obesity have normal-BMI cholesterol and blood pressure levels, study finds
A study found that many obese adults over 40 have cholesterol and blood pressure levels similar to those with a healthy weight, largely due to the effectiveness of statins and blood-pressure medications. In some cases, people with obesity were 'better off' than those of a healthy weight.
- Statins and blood pressure drugs changing health risks of obesity, study suggests
A 25-year study in the Lancet found that people over 40 with obesity have comparable blood pressure and cholesterol control to their peers with normal BMI, likely due to increased use of statins and blood pressure medications. The study tracked cardiovascular risk factors during an era of expanded access to these drugs.
- Craze for XXL snacks raises obesity fears in China
China is experiencing a surge in XXL-sized snacks sold in dedicated retail stores, sparking concerns about rising obesity rates, particularly among children, with 19 percent now overweight.
- STAT+: Investor Clive Meanwell on designing biotechs for population health, and AI’s role as a catalyst
Clive Meanwell, chairman of Population Health Partners, leveraged a competitive bidding war between Pfizer and Novo Nordisk for obesity startup Metsera, which reached a $10 billion offer. He now focuses on AI-driven solutions to address large-scale health challenges through innovative technologies and business models.
- I was a 400-pound FBI agent. I used obesity as a weapon... here's how the disguise helped me take down America's most notorious crime family
An FBI agent used obesity as a disguise to infiltrate and dismantle America's most notorious crime family. The agent's method was crucial to the operation's success.
- I was a 400-pound FBI agent. I used obesity as a weapon... here's how the disguise helped me take down America's most notorious crime family
An FBI agent used obesity as a disguise to infiltrate and dismantle America's most notorious crime family. The agent's unconventional method involved leveraging their 400-pound physique as a tactical advantage.
- About 170,000 people in England expected to die from obesity-linked heart conditions by 2035
About 170,000 people in England are expected to die from obesity-linked heart conditions by 2035, according to the British Heart Foundation. The analysis projects 45 deaths per day from cardiovascular disease tied to obesity over the next decade if current trends continue.
- The sky is not falling. Americans are getting healthier.
The article highlights declining obesity and heart disease rates, increasing cancer survival rates, and a record high life expectancy in the U.S. It criticizes politicians from both parties for promoting costly and ineffective healthcare policies despite these positive health trends.
- What is pulmonary hypertension and why would a new GLP-1 help?
A 79-year-old patient with obesity, sleep apnea, and pulmonary hypertension received Eli Lilly's experimental drug retatrutide under a compassionate use program. The White House denied the drug was for President Trump after initial speculation.
- Obesity cases rising fastest in young adults
Obesity cases are rising fastest among young adults, with experts attributing the trend to the cost of living, the pandemic, and an increase in unhealthy food consumption.
- Weight-loss drug approved to treat sleep apnea in Canada
Health Canada has approved an injection medication to treat severe obstructive sleep apnea in adults with obesity. The drug, initially developed for weight loss, is now authorized for this specific sleep disorder in Canada.
- Judge rules government can’t stop SNAP dollars from buying candy and sugary drinks
A federal judge ruled the government cannot block Supplemental Nutrition Assistance Program (SNAP) benefits from being used to purchase candy and sugary drinks, citing violations of the law and the program's definition of 'food.' The decision affects 23 states where restrictions were planned or implemented as part of the 'Make America Healthy Again' campaign, which aimed to curb obesity and chronic diseases by limiting purchases of unhealthy items.
- Judge rules government can't stop SNAP dollars from buying candy and sugary drinks
A federal judge ruled the government cannot block SNAP benefits from purchasing candy and sugary drinks, citing violations of the program's definition of 'food.' The decision affects 23 states where restrictions were implemented or planned under the Trump administration's 'Make America Healthy Again' campaign, which aimed to curb obesity and chronic diseases by limiting unhealthy purchases.
- Judge rules government can't stop SNAP dollars from buying candy and sugary drinks
A federal judge ruled that the government cannot restrict Supplemental Nutrition Assistance Program (SNAP) benefits from being used to buy candy and sugary drinks, citing a legal conflict with Congress's definition of 'food.' The decision blocks restrictions in 23 states and challenges efforts by the Agriculture and Health Secretaries to promote healthier food choices through the 'Make America Healthy Again' campaign.
- New drug combo may preserve muscle during weight loss
A study finds combining apitegromab with tirzepatide may help preserve lean muscle while supporting weight loss in people with obesity.
- GLP-1 drugs linked to boosting testosterone, sperm count in men
GLP-1 drugs may enhance male fertility by increasing testosterone levels and improving sperm health in men with obesity, according to new research.
- Not all skinny: The French do get fat
France's healthcare system now reimburses anti-obesity drugs Wegovy and Mounjaro under strict conditions. The article discusses France's obesity rates and regional variations, while addressing the stereotype that French people don't get fat, noting it contains a partial truth compared to other EU nations.
- GLP-1 drugs linked to reduced cancer risk, researchers say
GLP-1 drugs, primarily used for weight loss and diabetes, are associated with reduced cancer risk, including for breast, colon, pancreatic, and liver cancers. Researchers suggest this may be due to weight loss and anti-inflammatory effects, but emphasize more studies are needed to confirm causality.
- GLP-1s drugs like Ozempic may actually boost fertility in men: study
A study suggests GLP-1 drugs like Ozempic may improve male fertility by aiding weight loss, which is linked to increased testosterone and better sperm quality in obese individuals.
- New nationwide focus on rural healthcare: Here’s why
A federal-state initiative will allocate $50 billion over five years to the Rural Health Transformation Program (RHTP), with Michigan receiving $173 million. The program aims to keep rural hospitals open and improve care delivery, addressing higher rates of premature deaths and chronic diseases like heart disease, cancer, and obesity in rural areas.
- In Japan, life lessons in healthy eating
The article highlights the significantly lower obesity rate in Japan compared to the U.S., exploring how the Japanese diet and school initiatives promote healthy eating habits among children.
- Middle-aged adults taking GLP-1s for obesity can save over $192K on lifetime medical costs, higher if they don’t have college degrees, new study finds
A study by the National Bureau of Economic Research found that middle-aged adults using GLP-1 drugs for obesity could save $192,735 in lifetime medical costs on average, with higher savings ($220,000) for those without college degrees. The study attributes these savings to GLP-1s' direct impact on appetite and metabolism, which benefits individuals with limited time for diet/exercise regimens.
- Obesity Is Now Brazil Top Health Risk, Overtaking High Blood Pressure
Obesity has become Brazil's leading health risk, surpassing high blood pressure as the top factor. The data comes from a global disease study published in The Lancet, which attributes the shift to urban lifestyles, reduced physical activity, and processed food consumption.
- Some U.S. employers are dropping weight loss drug coverage as use surges
Some U.S. employers are discontinuing coverage for weight loss drugs as usage increases, with 10% of large employers planning to eliminate the benefit next year due to rising costs.
- STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
AstraZeneca's investigational GLP-1 pill, elecoglipron, demonstrated significant weight loss in a Phase 2 obesity trial (11.2% after 36 weeks) and improved blood sugar control in a diabetes trial (1.74 percentage-point A1C reduction). Results were compared to oral Ozempic, which showed a smaller A1C decrease in the same study.
- Monthly GLP-1 for Obesity Promising as More Manageable Alternative
An ultra-long-acting investigational GLP-1 agonist demonstrated significant weight loss in individuals with overweight or obesity, with continued reductions observed after transitioning to once-monthly dosing.
- Smartphone use associated with depression, obesity and lack of sleep in teens, study finds - as Keir Starmer pushes to make it illegal for children to send, see and receive naked photos
A study links smartphone use to depression, obesity, and sleep deprivation in teens. Keir Starmer advocates for a law banning children from sending, seeing, or receiving naked photos.
- Opinion: American horses are obese, too
Fifty-one percent of mature light-breed horses in the US are obese, the highest rate globally, comparable to Britain and twice that of Australia or Denmark. The US also leads the G7 in human obesity rates.
- 'Bariatric Surgery-Level' Weight Loss With Novel Triple-Agonist
Participants with obesity achieved weight loss comparable to bariatric surgery and showed improvements in two obesity-related conditions while taking a once-weekly investigational triple hormone receptor agonist. The treatment is described as a novel approach for managing obesity.
- Your ‘dad bod’ could raise your kids’ risk for obesity and disease — before they’re even conceived
New research indicates that a man's health, particularly being overweight ('dad bod'), before and during parenthood can increase children's risks for obesity and disease, even before conception. The study highlights the role of paternal health in child development outcomes.
- Top ultra-processed food researchers call for sweeping policy change: ‘The system is rigged’
Top ultra-processed food researchers advocate for policy changes, citing bipartisan public concern over health risks like obesity and diabetes. A survey shows majority support for government interventions such as testing additives for safety, banning artificial dyes, and reducing sugar and salt in foods.
- Obesity doesn’t equate to ill health: why the ‘disease’ label doesn’t always fit
The article discusses how obesity does not always equate to poor health and emphasizes that the 'disease' label may not apply universally. It highlights the importance of considering individual variations in health outcomes related to excess body weight for effective healthcare, policy, and research.
- Daily briefing: What it will take to stop the spiralling Ebola outbreak
The article discusses how lessons from past epidemics may help contain the current Ebola outbreak. It also touches on a rocket explosion's impact on NASA's Moon plans and the debate over reclassifying obesity into two diagnoses.
- When obesity, smoking and alcohol aren't to blame: Poor sleep fuelling cancer surge in under 50s
Poor sleep is contributing to a rise in cancer cases among people under 50, independent of factors like obesity, smoking, and alcohol. The article highlights sleep as a key driver in this cancer surge.
- This tomato-soy juice reduced inflammation in just four weeks
A specially formulated tomato-soy juice containing natural plant compounds was found to reduce inflammation linked to obesity in a clinical study. Healthy adults with obesity who consumed the juice daily for four weeks experienced significant decreases in key inflammatory proteins, unlike those who drank a control tomato juice.
- Weight loss drugs GLP-1s are shifting fashion and food trends
The rising use of GLP-1 weight-loss drugs is influencing fashion and food industries, with clothing brands adjusting designs for body fluctuations and wedding retailers requiring size waivers. An HSBC report warns reduced food expenditures could cut consumer spending by 7% in regions with high obesity rates like Eastern Europe, Latin America, and the US.
- Weight-loss jabs didn't work for me and I thought I was stuck being obese forever... until I was diagnosed with this condition. Now I've finally lost three stone. It's so common - these are the signs you have it too
A person struggled with weight-loss jabs and obesity until being diagnosed with an undisclosed medical condition, leading to significant weight loss. The article highlights common signs of the condition.